Tumor inoculation site affects the development of cancer cachexia and muscle wasting
- PMID: 26016447
- DOI: 10.1002/ijc.29620
Tumor inoculation site affects the development of cancer cachexia and muscle wasting
Abstract
The phenotype and severity of cancer cachexia differ among tumor types and metastatic site in individual patients. In this study, we evaluated if differences in tumor microenvironment would affect the development of cancer cachexia in a murine model, and demonstrated that body weight, adipose tissue and gastrocnemius muscle decreased in tumor-bearing mice. Interestingly, a reduction in heart weight was observed in the intraperitoneal tumor group but not in the subcutaneous group. We evaluated 23 circulating cytokines and members of the TGF-β family, and found that levels of IL-6, TNF-α and activin A increased in both groups of tumor-bearing mice. Eotaxin and G-CSF levels in the intraperitoneal tumor group were higher than in the subcutaneous group. Atrogin 1 and MuRF1 mRNA expressions in the gastrocnemius muscle increased significantly in both groups of tumor-bearing mice, however, in the myocardium, expression of these mRNAs increased in the intraperitoneal group but not in subcutaneous group. Based on these results, we believe that differences in microenvironment where tumor cells develop can affect the progression and phenotype of cancer cachexia through alterations in various circulating factors derived from the tumor microenvironment.
Keywords: cancer cachexia; colorectal cancer; cytokine; muscle wasting; tumor microenvironment.
© 2015 UICC.
Similar articles
-
Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.Oncol Rep. 2015 May;33(5):2261-8. doi: 10.3892/or.2015.3845. Epub 2015 Mar 9. Oncol Rep. 2015. PMID: 25760630
-
Elevated expression of activins promotes muscle wasting and cachexia.FASEB J. 2014 Apr;28(4):1711-23. doi: 10.1096/fj.13-245894. Epub 2013 Dec 30. FASEB J. 2014. PMID: 24378873
-
Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.Metabolism. 2013 Oct;62(10):1495-502. doi: 10.1016/j.metabol.2013.05.018. Epub 2013 Jul 15. Metabolism. 2013. PMID: 23866982
-
Muscle wasting in cancer.Int J Biochem Cell Biol. 2013 Oct;45(10):2215-29. doi: 10.1016/j.biocel.2013.05.032. Epub 2013 Jun 11. Int J Biochem Cell Biol. 2013. PMID: 23770121 Review.
-
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Semin Cancer Biol. 2016 Feb;36:95-104. doi: 10.1016/j.semcancer.2016.01.002. Epub 2016 Jan 21. Semin Cancer Biol. 2016. PMID: 26804424 Free PMC article. Review.
Cited by
-
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.Front Oncol. 2024 Jan 26;14:1303543. doi: 10.3389/fonc.2024.1303543. eCollection 2024. Front Oncol. 2024. PMID: 38344209 Free PMC article.
-
Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions.Metabolites. 2023 Sep 20;13(9):1024. doi: 10.3390/metabo13091024. Metabolites. 2023. PMID: 37755304 Free PMC article. Review.
-
The role of myokines in cancer: crosstalk between skeletal muscle and tumor.BMB Rep. 2023 Jul;56(7):365-373. doi: 10.5483/BMBRep.2023-0064. BMB Rep. 2023. PMID: 37291054 Free PMC article. Review.
-
Cancer cachexia: molecular mechanisms and treatment strategies.J Hematol Oncol. 2023 May 22;16(1):54. doi: 10.1186/s13045-023-01454-0. J Hematol Oncol. 2023. PMID: 37217930 Free PMC article. Review.
-
Biomarkers and mechanisms associated with cancer-induced cardiac cachexia: A systematic review.J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1900-1905. doi: 10.1002/jcsm.13267. Epub 2023 May 21. J Cachexia Sarcopenia Muscle. 2023. PMID: 37211636 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
